Dynamic regulation of innate immunity by ubiquitin and ubiquitin-like proteins

Cytokine and Growth Factor Reviews

Volumn 24, Issue 6, 2013, Pages 559-570

  Liu, Xing ^a   Wang, Qiang ^a   Chen, Wei ^a   Wang, Chen ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Innate immunity; ISG15; Signal transduction; SUMO; Ubiquitin

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CRYOPYRIN; I KAPPA B KINASE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; POLYUBIQUITIN; RETINOIC ACID INDUCIBLE PROTEIN I; SUMO 1 PROTEIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN; UBIQUITIN LIKE PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; BACTERIAL IMMUNITY; ENZYME ACTIVATION; HOST RESISTANCE; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; VIRUS IMMUNITY;

ANIMALIA;

INNATE IMMUNITY; ISG15; SIGNAL TRANSDUCTION; SUMO; UBIQUITIN;

ANIMALS; IMMUNITY, INNATE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, PATTERN RECOGNITION; TOLL-LIKE RECEPTORS; UBIQUITINS;

EID: 84888292851     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2013.07.002     Document Type: Review

References (131)

1. Varshavsky A. The ubiquitin system, an immense realm. Annual Review of Biochemistry 2012, 81:167-176.
2. Hochstrasser M. Origin and function of ubiquitin-like proteins. Nature 2009, 458:422-429.
3. Grabbe C., Husnjak K., Dikic I. The spatial and temporal organization of ubiquitin networks. Nature Reviews Molecular Cell Biology 2011, 12:295-307.
4. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
5. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
6. Barbalat R., Ewald S.E., Mouchess M.L., Barton G.M. Nucleic acid recognition by the innate immune system. Annual Review of Immunology 2011, 29:185-214.
7. Hochstrasser M. Ubiquitin-dependent protein degradation. Annual Review of Genetics 1996, 30:405-439.
8. Hershko A., Ciechanover A. The ubiquitin system. Annual Review of Biochemistry 1998, 67:425-479.
9. Pickart C.M. Mechanisms underlying ubiquitination. Annual Review of Biochemistry 2001, 70:503-533.
10. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB Journal 1997, 11:1245-1256.
11. Kirisako T., Kamei K., Murata S., Kato M., Fukumoto H., Kanie M., et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO Journal 2006, 25:4877-4887.
12. Hochstrasser M. Lingering mysteries of ubiquitin-chain assembly. Cell 2006, 124:27-34.
13. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999, 96:635-644.
14. Arimoto K., Funami K., Saeki Y., Tanaka K., Okawa K., Takeuchi O., et al. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15856-15861.
15. Tokunaga F., Sakata S., Saeki Y., Satomi Y., Kirisako T., Kamei K., et al. Involvement of linear polyubiquitylation of NEMO in NF-kappa B activation. Nature Cell Biology 2009, 11. 123-U40.
16. Zotti T., Uva A., Ferravante A., Vessichelli M., Scudiero I., Ceccarelli M., et al. TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation. Journal of Biological Chemistry 2011, 286:22924-22933.
17. Hochstrasser M. Evolution and function of ubiquitin-like protein-conjugation systems. Nature Cell Biology 2000, 2. E153-7.
18. Kim K.I., Giannakopoulos N.V., Virgin H.W., Zhang D.E. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Molecular and Cellular Biology 2004, 24:9592-9600.
19. Wong J.J., Pung Y.F., Sze N.S., Chin K.C. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:10735-10740.
20. Dastur A., Beaudenon S., Kelley M., Krug R.M., Huibregtse J.M. Herc5 an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. Journal of Biological Chemistry 2006, 281:4334-4338.
21. Yuan W., Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO Journal 2001, 20:362-371.
22. Malakhova O., Malakhov M., Hetherington C., Zhang D.E. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. Journal of Biological Chemistry 2002, 277:14703-14711.
23. Johnson E.S. Protein modification by SUMO. Annual Review of Biochemistry 2004, 73:355-382.
24. Hay R.T. SUMO: a history of modification. Molecular Cell 2005, 18:1-12.
25. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nature Reviews Molecular Cell Biology 2007, 8:947-956.
26. Cheng J., Kang X., Zhang S., Yeh E.T. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007, 131:584-595.
27. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Molecular Cell 1998, 2:233-239.
28. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology 2010, 11:373-384.
29. Akira S., Takeda K. Toll-like receptor signalling. Nature Reviews Immunology 2004, 4:499-511.
30. O'Neill L.A.J., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology 2007, 7:353-364.
31. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001, 412:346-351.
32. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103:351-361.
33. Xia Z.P., Sun L.J., Chen X., Pineda G., Jiang X.M., Adhikari A., et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009, 461:114-119.
34. Kawagoe T., Takeuchi O., Takabatake Y., Kato H., Isaka Y., Tsujimura T., et al. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nature Immunology 2009, 10:965-972.
35. Shi H.X., Liu X., Wang Q., Tang P.P., Liu X.Y., Shan Y.F., et al. Mitochondrial ubiquitin ligase MARCH5 promotes TLR7 signaling by attenuating TANK action. PLoS Pathogens 2011, 7:e1002057.
36. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999, 18:6867-6874.
37. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997, 91:243-252.
38. Israel A. The IKK complex: an integrator of all signals that activate NF-kappa B?. Trends in Cell Biology 2000, 10:129-133.
39. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKK-gamma is an essential regulatory subunit of the I kappa B kinase complex. Nature 1998, 395:297-300.
40. Wu C.J., Conze D.B., Li T., Srinivasula S.M., Ashwell J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nature Cell Biology 2006, 8:398-406.
41. Laplantine E., Fontan E., Chiaravalli J., Lopez T., Lakisic G., Veron M., et al. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO Journal 2009, 28:2885-2895.
42. Rahighi S., Ikeda F., Kawasaki M., Akutsu M., Suzuki N., Kato R., et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappa B activation. Cell 2009, 136:1098-1109.
43. Tang E.D., Wang C.Y., Xiong Y., Guan K.L. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. Journal of Biological Chemistry 2003, 278:37297-37305.
44. Hoshino K., Sugiyama T., Matsumoto M., Tanaka T., Saito M., Hemmi H., et al. I kappa B kinase-alpha is critical for interferon-alpha production induced by toll-like receptors 7 and 9. Nature 2006, 440:949-953.
45. Yang K., Puel A., Zhang S.Y., Eidenschenk C., Ku C.L., Casrouge A., et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005, 23:465-478.
46. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005, 434:1035-1040.
47. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunology 2004, 5:1061-1068.
48. Honda K., Yanai H., Mizutani T., Negishi H., Shimada N., Suzuki N., et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15416-15421.
49. Guiducci C., Ghirelli C., Marloie-Provost M.A., Matray T., Coffman R.L., Liu Y.J., et al. PI3K is critical for the nuclear translocation of IRF-7 and type IIFN production by human plasmacytoid predendritic cells in response to TLR activation. Journal of Experimental Medicine 2008, 205:315-322.
50. Doyle S.L., Jefferies C.A., Feighery C., O'Neill L.A.J. Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. Journal of Biological Chemistry 2007, 282:36953-36960.
51. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nature Immunology 2004, 5:503-507.
52. Cusson-Hermance N., Khurana S., Lee T.H., Fitzgerald K.A., Kelliher M.A. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. Journal of Biological Chemistry 2005, 280:36560-36566.
53. Chang M., Jin W., Sun S.C. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nature Immunology 2009, 10:1089-1095.
54. Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes and Development 1995, 9:1586-1597.
55. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 1995, 267:1485-1488.
56. Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A.M., et al. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 1998, 396:590-594.
57. Wang C., Chen T., Zhang J., Yang M., Li N., Xu X., et al. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nature Immunology 2009, 10:744-752.
58. Zhao W., Wang L.J., Zhang M., Yuan C., Gao C.J. E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages. Journal of Immunology 2012, 188:2567-2574.
59. Ryo A., Suizu F., Yoshida Y., Perrem K., Liou Y.C., Wulf G., et al. Regulation of NF-kappa B signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Molecular Cell 2003, 12:1413-1426.
60. Maine G.N., Mao X.C., Komarck C.M., Burstein E. COMMD1 promotes the ubiquitination of NF-kappa B subunits through a cullin-containing ubiquitin ligase. EMBO Journal 2007, 26:436-447.
61. Saccani S., Marazzi I., Beg A.A., Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappa B response. Journal of Experimental Medicine 2004, 200:107-113.
62. Tanaka T., Grusby M.J., Kaisho T. PDLIM2-mediated termination of transcription factor NF-kappa B activation by intranuclear sequestration and degradation of the p65 subunit. Nature Immunology 2007, 8:584-591.
63. Liu B., Yang R., Wong K.A., Getman C., Stein N., Teitell M.A., et al. Negative regulation of NF-kappa B signaling by PIAS1. Molecular and Cellular Biology 2005, 25:1113-1123.
64. Liu X., Chen W., Wang Q., Li L., Wang C. Negative regulation of TLR inflammatory signaling by the SUMO-deconjugating enzyme SENP6. PLoS Pathogens 2013, 9:e1003480.
65. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunology 2004, 5:730-737.
66. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
67. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunology 2005, 6:981-988.
68. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
69. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
70. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z.H., Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Molecular Cell 2005, 19:727-740.
71. Michallet M.C., Meylan E., Ermolaeva M.A., Vazquez J., Rebsamen M., Curran J., et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 2008, 28:651-661.
72. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006, 439:208-211.
73. Belgnaoui S.M., Paz S., Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Current Opinion in Immunology 2011, 23:564-572.
74. van Zuylen W.J., Doyon P., Clement J.F., Khan K.A., D'Ambrosio L.M., Do F., et al. Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity. PLoS Pathogens 2012, 8:e1002747.
75. Liu X.Y., Wei B., Shi H.X., Shan Y.F., Wang C. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Research 2010, 20:994-1011.
76. Lin R., Paz S., Hiscott J. Tom70 imports antiviral immunity to the mitochondria. Cell Research 2010, 20:971-973.
77. Yang K., Shi H., Qi R., Sun S., Tang Y., Zhang B., et al. Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells. Molecular Biology of the Cell 2006, 17:1461-1471.
78. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunology 2003, 4:491-496.
79. McWhirter S.M., Fitzgerald K.A., Rosains J., Rowe D.C., Golenbock D.T., Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:233-238.
80. Clement J.F., Bibeau-Poirier A., Gravel S.P., Grandvaux N., Bonneil E., Thibault P., et al. Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. Journal of Virology 2008, 82:3984-3996.
81. Lin R., Heylbroeck C., Pitha P.M., Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Molecular and Cellular Biology 1998, 18:2986-2996.
82. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455:674-678.
83. Zhong B., Yang Y., Li S., Wang Y.Y., Li Y., Diao F., et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008, 29:538-550.
84. Sun W., Li Y., Chen L., Chen H., You F., Zhou X., et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:8653-8658.
85. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
86. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
87. Gack M.U., Kirchhofer A., Shin Y.C., Inn K.S., Liang C., Cui S., et al. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:16743-16748.
88. Gack M.U., Albrecht R.A., Urano T., Inn K.S., Huang I.C., Carnero E., et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host & Microbe 2009, 5:439-449.
89. Inn K.S., Gack M.U., Tokunaga F., Shi M., Wong L.Y., Iwai K., et al. Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Molecular Cell 2011, 41:354-365.
90. Zhao T., Yang L., Sun Q., Arguello M., Ballard D.W., Hiscott J., et al. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nature Immunology 2007, 8:592-600.
91. Hiscott J. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine and Growth Factor Reviews 2007, 18:483-490.
92. Belgnaoui S.M., Paz S., Samuel S., Goulet M.L., Sun Q., Kikkert M., et al. Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex. Cell Host & Microbe 2012, 12:211-222.
93. Oshiumi H., Matsumoto M., Hatakeyama S., Seya T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. Journal of Biological Chemistry 2009, 284:807-817.
94. Gao D., Yang Y.K., Wang R.P., Zhou X., Diao F.C., Li M.D., et al. REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS ONE 2009, 4:e5760.
95. Oshiumi H., Miyashita M., Inoue N., Okabe M., Matsumoto M., Seya T. The ubiquitin ligase riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host & Microbe 2010, 8:496-509.
96. Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
97. Zeng W., Xu M., Liu S., Sun L., Chen Z.J. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Molecular Cell 2009, 36:315-325.
98. Ashida H., Kim M., Schmidt-Supprian M., Ma A., Ogawa M., Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nature Cell Biology 2010, 12:66-73. (sup pp 1-9).
99. Mao A.P., Li S., Zhong B., Li Y., Yan J., Li Q., et al. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. Journal of Biological Chemistry 2010, 285:9470-9476.
100. Tsuchida T., Zou J., Saitoh T., Kumar H., Abe T., Matsuura Y., et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010, 33:765-776.
101. Zhang J., Hu M.M., Wang Y.Y., Shu H.B. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. Journal of Biological Chemistry 2012, 287:28646-28655.
102. Tanaka Y., Chen Z.J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Science Signaling 2012, 5:ra20.
103. Arimoto K., Takahashi H., Hishiki T., Konishi H., Fujita T., Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:7500-7505.
104. Chen W., Han C., Xie B., Hu X., Yu Q., Shi L., et al. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 2013, 152:467-478.
105. Paz S., Vilasco M., Arguello M., Sun Q., Lacoste J., Nguyen T.L., et al. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. Molecular and Cellular Biology 2009, 29:3401-3412.
106. You F.P., Sun H., Zhou X., Sun W.X., Liang S.M., Zhai Z.H., et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nature Immunology 2009, 10:1300-1308.
107. Zhou X., You F.P., Chen H.H., Jiang Z.F. Poly(C)-binding protein 1 (PCBP1) mediates housekeeping degradation of mitochondrial antiviral signaling (MAVS). Cell Research 2012, 22:717-727.
108. Zhong B., Zhang Y., Tan B., Liu T.T., Wang Y.Y., Shu H.B. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. Journal of Immunology 2010, 184:6249-6255.
109. Zhong B., Zhang L., Lei C., Li Y., Mao A.P., Yang Y., et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 2009, 30:397-407.
110. Cui J., Li Y.Y., Zhu L., Liu D., Zhou S.Y., Wang H.L.Y., et al. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nature Immunology 2012, 13:387-395.
111. Nakhaei P., Mesplede T., Solis M., Sun Q., Zhao T., Yang L., et al. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathogens 2009, 5:e1000650.
112. Bibeau-Poirier A., Gravel S.P., Clement J.F., Rolland S., Rodier G., Coulombe P., et al. Involvement of the IkappaB kinase (IKK)-related kinases tank-binding kinase 1/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation. Journal of Immunology 2006, 177:5059-5067.
113. Saitoh T., Tun-Kyi A., Ryo A., Yamamoto M., Finn G., Fujita T., et al. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nature Immunology 2006, 7:598-605.
114. Yu Y.X., Hayward G.S. The ubiquitin E3 ligase RAUL negatively regulates type I interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 2010, 33:863-877.
115. Higgs R., Gabhann J.N., Ben Larbi N., Breen E.P., Fitzgerald K.A., Jefferies C.A. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. Journal of Immunology 2008, 181:1780-1786.
116. Yang K., Shi H.X., Liu X.Y., Shan Y.F., Wei B., Chen S., et al. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. Journal of Immunology 2009, 182:3782-3792.
117. Mi Z., Fu J., Xiong Y., Tang H. SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein Cell 2010, 1:275-283.
118. Kubota T., Matsuoka M., Chang T.H., Tailor P., Sasaki T., Tashiro M., et al. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. Journal of Biological Chemistry 2008, 283:25660-25670.
119. Ran Y., Liu T.T., Zhou Q., Li S., Mao A.P., Li Y., et al. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation. Journal of Molecular Cell Biology 2011, 3:283-292.
120. Shi H.X., Yang K., Liu X., Liu X.Y., Wei B., Shan Y.F., et al. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Molecular and Cellular Biology 2010, 30:2424-2436.
121. Lu G., Reinert J.T., Pitha-Rowe I., Okumura A., Kellum M., Knobeloch K.P., et al. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cellular and Molecular Biology (Noisy-le-grand). 2006, 52:29-41.
122. Lenschow D.J., Lai C., Frias-Staheli N., Giannakopoulos N.V., Lutz A., Wolff T., et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:1371-1376.
123. Fritz J.H., Ferrero R.L., Philpott D.J., Girardin S.E. Nod-like proteins in immunity, inflammation and disease. Nature Immunology 2006, 7:1250-1257.
124. Sirard J.C., Vignal C., Dessein R., Chamaillard M. Nod-like receptors: cytosolic watchdogs for immunity against pathogens. PLoS Pathogens 2007, 3:e152.
125. Kanneganti T.D., Lamkanfi M., Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007, 27:549-559.
126. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
127. Chen G., Shaw M.H., Kim Y.G., Nunez G. NOD-like receptors: role in innate immunity and inflammatory disease. Annual Review of Pathology-Mechanisms of Disease 2009, 4:365-398.
128. Hasegawa M., Fujimoto Y., Lucas P.C., Nakano H., Fukase K., Nunez G., et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO Journal 2008, 27:373-383.
129. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., Kelliher M.A. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. Journal of Biological Chemistry 2007, 282:36223-36229.
130. Damgaard R.B., Nachbur U., Yabal M., Wong W.W., Fiil B.K., Kastirr M., et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Molecular Cell 2012, 46:746-758.
131. Labbe K., McIntire C.R., Doiron K., Leblanc P.M., Saleh M. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient Caspase-1 activation by the inflammasome. Immunity 2011, 35:897-907.